Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
rubber dildos.
Popular Articles

Obama, Pope Focus On Abortion, 'Life' Issues In First Meeting
In their first meeting, President Obama and Pope Benedict XVI on Friday discussed their views on abortion, embryonic stem cell research and the rights of health care workers to object to procedures and services that go against their beliefs, the Los Angeles Times reports. During a 30-minute discussion, the pope expressed to Obama his beliefs about "the defense and promotion of life and the right to abide by one"s conscience," according to the Vatican. The Times reports that the statement was a "clear reference" to debates over abortion rights, embryonic stem cell research and "conscience" protections for health care providers who refuse care on moral or religious grounds (Chu, Los Angeles Times, 7/11).According to Time, Benedict showed "no intention of papering over differences on what the Vatican calls "life" issues," including abortion rights. Vatican spokesperson the Rev. Federico Lombardi said that the pope told him how Obama "explicitly expressed his commitment to reducing the number of abortions and to listen to the Church"s concerns on moral issues" (Israely, Time, 7/10). According to White House deputy national security aide Denis McDonough, Obama was "eager to find common ground on these issues and to work aggressively to do that" (Simpson/Feller, AP/Boston Globe, 7/11). However, "[I]t may just be that there"s issues that you can"t come to agreement on," McDonough added, noting that Obama believes that "you can disagree without being disagreeable" (Los Angeles Times, 7/11).Montsignor Georg Ganswein, the pope"s personal secretary, said that Obama was given a copy of "Dignitas Personae," or "The Dignity of a Person," a Vatican document released in December detailing the Roman Catholic Church"s most recent stance on bioethics issues (Time, 7/10). The document "hardened" the Church"s opposition to embryonic stem cell research, cloning and in vitro fertilization (AP/Boston Globe, 7/11). Obama assured the pope he would read the document that day on his flight from Italy to Ghana. Ganswein said that the document "can help the president better understand the position of the Catholic Church." Lombardi noted that it "would be ambiguous to hide or minimize what we believe," adding, "It"s not meant to be divisive or polemical" (Time, 7/10).
diet pills
Ferring Pharmaceuticals Announces Trade Name Firmagon (Degarelix ForInjection) For Advanced Prostate Cancer Treatment
Ferring Pharmaceuticals announced yesterday that the U.S.
News of the day
RCN Calls For EU Agreement On Sharps Injuries To Be Implemented Quickly
The Royal College of Nursing welcomed the signing of a joint agreement by European Federation of Public Service Unions (EPSU) and the European Hospital and Healthcare Employers Association (HOSPEEM). This is an EU-wide agreement which the RCN has played a key role in bringing about to prevent one million medical sharps injuries per year. Dr Peter Carter, Chief Executive of the Royal College of Nursing (RCN), said:
Health Insurance

Carbohydrate Acts As Tumor Suppressor

Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specialized complex sugar molecules (glycans) that anchor cells into place act as tumor suppressors in breast and prostate cancers. These glycans play a critical role in cell adhesion in normal cells, and their decrease or loss leads to increased cell migration by invasive cancer cells and metastasis. An increase in expression of the enzyme that produces these glycans, í²3GnT1, resulted in a significant reduction in tumor activity. The research was published in the journal Proceedings of the National Academy of Sciences. The specialized glycans are capable of binding to laminin and are attached to the í±-DG cell surface protein. This binding facilitates adhesion between epithelial and basement membrane cells and prevents cells from migrating. The team of scientists, led by Professor Minoru Fukuda, Ph.D., demonstrated that í²3GnT1 controls the synthesis of laminin-binding glycans in concert with the genes LARGE/LARGE2. Down-regulation of í²3GnT1 reduces the number of glycans, leading to greater movement by invasive cancer cells. However, when the researchers forced aggressive cancer cells to express í²3GnT1, the laminin-binding glycans were restored and tumor formation decreased. "These results indicate that certain carbohydrates on normal cells and enzymes that synthesize those glycans, such as í²3GnT1, function as tumor suppressors," said Dr. Fukuda." Upregulation of í²3GnT1 may become a novel way to treat cancer." Using antibodies, the team investigated the expression of both í±-DG and its associated glycans in both normal and cancerous cells. They found that the quantity of í±-DG was similar in both cell types, but the level of attached glycans was reduced in the cancer cells. Further study showed that prostate cancer cells that highly expressed the í±-DG glycans produced smaller tumors. The team also found that when they knocked down í²3GnT1 expression by RNA interference, which reduces protein expression, the amount of glycans decreased even when LARGE was overexpressed. The scientists demonstrated that í²3GnT1 plays a key role in forming laminin-binding glycans attached to í±-DG, which in turn reduces cancer cell movement. The study provides a new understanding of the role that complex carbohydrates play in cancer and could lead to new directions in the development of therapeutics. About Burnham Institute for Medical Research Burnham Institute for Medical Research is dedicated to revealing the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The Institute ranks among the top-four institutions nationally for NIH grant funding and among the top-25 organizations worldwide for its research impact. Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, infectious and inflammatory and childhood diseases. The Institute is known for its world-class capabilities in stem cell research and drug discovery technologies. Burnham is a nonprofit, public benefit corporation. Burnham Institute for Medical Research


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009